S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ENTX Entera Bio Ltd

2.39

0.00 (0.00%)

Pre Market

Last Updated: 03:29:47

Delayed by 15 minutes

Entera Bio shares surge on mid-stage osteoporosis study data

To read the full story on Seeking Alpha, click here.

Entera Bio (NASDAQ:ENTX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Entera Bio Charts.

Entera Bio (NASDAQ:ENTX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Entera Bio Charts.

Entera Bio Ltd News

Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
Monday 8 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.

Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
Wednesday 20 March 2024 (2 months ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B3 - Prospectus [Rule 424(b)(3)]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

More Entera Bio Ltd News Articles

Greene Concepts (PK)

Movement Industries (PK)

Kraig Biocraft Laborator... (QB)

Therapeutic Solutions (PK)

Elite Pharmaceuticals (QB)

Mullen Automotive

Innerscope Hearing Techn... (PK)

Alternet Systems (PK)

Digital Brand Media and ... (PK)

International Star (PK)

Enzolytics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions